Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
NCT00219362Phase 2Completed
- Sponsor
- Objectif Recherche Vaccins SIDA
- Start
- Apr 2004
- Primary completion
- Nov 2005
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of ALVAC-HIV vCP1452 in human immunodeficiency virus infection (HIV), sponsored by Objectif Recherche Vaccins SIDA. Started Apr 2004; status: completed.
02
Drugs
ALVAC-HIV vCP1452
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00219362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219362.